Abstract
Background
Quality of life (QoL) has become increasingly important in cancer treatment. It refers to the patient’s perception of the effects of the disease and therapy, and their impact on daily functioning and general feeling of well being.
Material and Methods
n this prospective study, a total of 100 patients treated at our institution, completed the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire and the specific EORTC QLQ-H&N35 module. The questionnaires were distributed to the patients between 12 and 60 months postoperatively.
Results
Global QoL score was 58.3 and mean score for functioning scale was 76.7. Fatigue (28.7 ± 26.1), followed by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and pain (26.3 ± 29.9) had highest symptom score on QLQ-C30. Fatigue (r=-0.488), insomnia (r=-0.416) and pain (r =-0.448) showed highest value for significantly negative correlation to global QoL. In the H&N35 module, restriction of mouth opening (43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva (37.3 ± 37.1) and eating in public (33.8 ± 31.9) were the four worst symptoms. Swallowing problem (r=-0.438), eating in public (r=-0.420) and persistent severe speech (r=-0.398) ranked as the three worst symptoms with highest value for significantly negative correlation to global QoL.
Conclusions
Longterm QoL after oncologic surgery and microvascular free flap reconstruction in patients with oral cancer is satisfactory. Measuring QoL should be considered as part of the evaluation of cancer treatment.
Key words:Longterm quality of life, oral cancer, oncologic surgery, microvascular free flap reconstruction.
Introduction
Generally, the evaluation of cancer treatment is focused on the survival rate, local control rate, or complication rate. The main disadvantage is that these endpoints were usually assessed from the physician´s points of view. Therefore quality of life (QoL) has become increasingly important in cancer therapy. It refers to the patient’s perception of the effects of the disease and the impact of the operation on the patient’s daily functioning. Due to debilitating problems with swallowing and speech as well as the psychological effects of loss of function and change in body image, QoL present a decisive role in patients with oral cancer (1). Numerous of well-validated QoL instruments are established in the field of oncology. Especially, the European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire C30 (EORTC QLQ-C30) and the Quality of Life Head and Neck module (EORTC QLQ-H&N35) were frequently used (2,3). Prospective QoL studies on patients suffering from head and neck cancer with more than 12 months of follow-up are rare in the current literature (4,5). The aim of this prospective study was to evaluate long-term QoL after oncologic surgery and immediate microvascular reconstruction in patients with oral cancer.
Material and Methods
- Study population
The prospective study was initiated after the local ethics committee of the Jena University Hospital gave its approval. Written informed consent was obtained from all participants. All patients had histological confirmed diagnoses of oral squamous cell carcinoma (OSCC) and underwent surgery at the Jena University Hospital with curative intent. After intraoral radical resection and lymph node surgery in accordance with preoperative clinical and radiological examination, all patients received immediate microvascular free flap reconstruction.
- Assessment of QoL
Patients completed the German versions of the EORTC QLQ-C30 and the EORTC QLQ-H&N35 at between 12 and 60 months after treatment.
The EORTC QLQ-C30 consisted of five functional scales (physical function, cognitive function, role function, emotional function and social function), three symptom scales (fatigue, emesis and pain), one scale for the overall health status/QoL and six single items (breathing, sleep disorders, appetite loss, constipation, diarrhea and economic sequelae) (3).
The EORTC QLQ-H&N35 comprises seven multi-item scales (pain, swallowing, senses, speech, social eating, social contact, sexuality) and eleven single items. All scales and single item variables were transformed into a score from 0 to 100 (2).
A high score for the functioning scale and for the global QoL scale represents a better level of functioning, whereas higher levels in the symptom scales or the single-item scales of the EORTC QLQ-C30 and the H&N module denotes a high level of symptoms or problems.
- Statistical analysis
Statistical analyses were conducted using the SPSS/PC statistical program (version 22.0 for Windows; SPSS, Inc., Chicago, IL). Using the Pearson’s correlation coefficient (r), we investigated the potential relationships between QoL global score and general, head and neck symptoms.
In general, r > 0 indicates positive relationship, r < 0 indicates negative relationship, while r = 0 indicates no relationship (or that the variables are independent and not related). The strength of relationship is strong for value of r -1.0 to -0.5 or 0.5 to 1.0, moderate for value of -0.5 to -0.3 or 0.3 to 0.5, weak for value of -0.3 to -0.1 or 0.1 to 0.3 and none or very weak for value of -0.1 to 0.1. It is well recognised that a correlation between two variables exists when r is superior to 0.3 and that this correlation increases as r approaches 1 (6).
Levels of statistical significance have been calculated at the 5% level of probability (p <0.05).
Results
A total of 100 patients (69 male, 31 female), mean age 60.1±11.2 years (range 40-83 years), were enrolled in this study. The location of the tumour and the stage of disease are shown in Table 1. In the majority of cases (42 %), the tumour was located on the floor of the mouth and 67 out of 100 patients presented with an early stage I/II of disease. The radial forearm flap was most commonly used ( Table 1). In all, adjuvant therapy was indicated in 74 cases. 59 Patients underwent postoperative radiotherapy and further 15 patients received postoperative radiochemotherapy.
Table 1. Clinical characteristics of the 100 patients.
- EORTC QLQ-C30
The results of the functional scales are shown in Table 2. The mean QoL global score was 58.3 and the mean score for functioning scale of 76.7.
Table 2. Results of the QLQ-C30 overall health status and functional scales.
The results of the general symptom scales and the bivariate analyses between global QoL score and general symptoms are shown in Table 3. Fatigue (28.7 ± 26.1), followed by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and pain (26.3 ± 29.9) were the main general complaints.
Table 3. Results of the QLQ-C30 and the bivariate analyses between QoL score and general symptoms (r-QoL).
- Global QoL score was
• significantly (p<0.05) negative correlated with dyspnea (r=-0.250) and financial difficulties (r=-0.212)
• very significantly (p<0.01) negative correlated with fatigue (r=-0.488), nausea (r=-0.364), pain (r =-0.488), insomnia (r=-0.416), appetite loss (r=-0.388), and diarrhea (r=-0.262).
However, global QoL score was not correlated with constipation.
- EORTC QLQ-H&N35
The results from the EORTC QLQ-H&N35 scales and items are shown in Table 4. Restriction of mouth opening (43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva (37.3 ± 37.1) and eating in public (33.8 ± 31.9 ) ranked as the four worst symptoms.
Table 4. Results of the QLQ-H&N35 and the bivariate analyses between QoL score and symptoms (r-QoL).
- Global QoL score was
• significantly (p<0.05) negative correlated with problems with pain medication (r=-0.207), food supplements (r=-0.237) and weight loss (r=-0.203).
• very significantly (p<0.01) negative correlated with pain (r=-0.385), swallowing (r=-0.438), speech (r=-0.398), social eating (r=-0.420), social contact (r=-0.405), sexual problems (r=-0.312), open mouth (r=-0.391), cough (r=-0.257) and feeling ill (r=-0.412).
There was no correlation between global QoL and problems with senses, teeth, dry mouth, sticky saliva, feeding tube and weight gain.
Discussion
QoL has become a increasingly important in the assessment of any therapy in oncology. There is a rapidly increasing number of published studies investigating QoL in patients with head and neck cancer (2,5-8). Meanwhile numerous of well-validated QoL instruments are now available which have been categorized in three types of methods.The first category includes the generic type, e.g. the Short Form-36 (SF-36), the second the cancer specific type, e.g. the Functional Assessment of Cancer Treatment (FACT-G), the EORTC QLQ-C30, and the third the cancer site-specific type, e.g. the head and neck modules in EORTC QLQ-H&N35, and FACT (FACT-HN) (2,3,9-11).
Microvascular free tissue transfers have been used routinely for head and neck reconstruction in order to improve the functional and esthetic outcomes (6). Therefore, the aim of the present study was to evaluate long-term QoL after surgery and immediate free flap reconstruction in patients with OSCC.
We used a general QoL questionnaire, adapted to all cancer patients, the EORTC QLQ-C30, and a specific questionnaire, the EORTC QLQ-H&N35 which were completed at between 12 and 60 months after treatment.
Studies showed that surgical treatment of oral cancer led to a temporary deterioration of QoL issues. However, the levels of these scores improved until the end of the first postoperative year (7,12). In addition, there are not any further changes in QoL in the follow years after treatment (13). Therefore, it is generally accepted that QoL at one year post-treatment is a good indicator of QoL at long term in disease-free head and neck cancer patients (14,15).
With a global QoL score close to 60 %, long-term QoL of our patients was comparable to the study from Wan Leung et al.(1). Meanwhile other authors refer to a global QoL score close to 70 % (6,16). Furthermore the mean score for functioning scale of 76.7 % was similar to the results from Pierre et al. with a mean score of 82.5 % (6). Overall, persistent fatigue (28.7 ± 26.1) , followed by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and pain (26.3 ± 29.9) were the main general complaints of our patients and significantly negative correlated with global QoL (fatigue: r=-0.488, financial problems: r=-0.212, insomnia: r=-0.416, pain: r=-0.448). Pierre et al. and Wan Leung et al. corroborated these results, as they also refer that fatigue and insomnia are the main general symptoms (6,1).
In the H&N35 module restriction of mouth opening (43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva (37.3 ± 37.1) and eating in public (33.8 ± 31.9) denote a high level of problems. The limitation of mouth opening can be induced by surgical treatment (17,18). Furthermore the adjuvant radiotherapy is responsible for the limitation of mouth opening long term after treatment and for salivary dysfunction (19-22). Swallowing problem (r=-0.438), persistent severe speech (r=-0.398) and eating in public (r=-0.420) were significantly negative correlated with global QoL. These complaints should be properly identified in order to rehabilitate and nutritionally support patients. Therefore a nutritionist and a rehabilitation therapist should be part of the multidisciplinary team planning the care of these patients (8). Furthermore, studies reported that that QoL of patients with OSCC can benefit from psychological group therapy and psychoeducational treatment (23,24).
Feeling ill (r=-0.412) and pain (r=-0.385) were also significantly negative correlated with global QoL. Chronic pain is often a consequence of neck dissection and common after surgical treatment (25). Terrell et al. reported that neck dissection is associated with significant decline in global QoL (26). Postoperative rehabilitation should incorporated in the standard management in these patients. Pfister et al. found a significant reduction in pain and dysfunction in patients undergoing neck dissection who received weekly acupuncture versus usual care (27).
The design of the current study has some limitations. We did not subclassify the patients according to the adjuvant therapy. However, the size of the subgroup of patients with surgery alone and postoperative radiochemotherapy was too small and inhomogeneous for comparison of surgical and combined therapy. Furthermore, the focus of this study was to evaluate the effect of immediate microvascular free flap reconstruction on long-term QoL.
Conclusions
The results of the present evaluation with the EORTC instruments show that longterm QoL after tumor resection and immediate microvascular free flap reconstruction in patients with OSCC seems to be acceptable. The highest symptom score on QLQ-C30 was for fatigue, followed by financial problems, insomnia and pain. In the H&N35 module, restriction of mouth opening, dry mouth, sticky saliva and eating in public ranked as the four worst symptoms. Measuring QoL should be considered as part of the evaluation of cancer treatment.
References
- 1.Wan Leung S, Lee TF, Chien CY, Chao PJ, Tsai WL, Fang FM. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer. 2011;11:128. doi: 10.1186/1471-2407-11-128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17:1008–19. doi: 10.1200/JCO.1999.17.3.1008. [DOI] [PubMed] [Google Scholar]
- 3.Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
- 4.Infante-Cossio P, Torres-Carranza E, Cayuela A, Gutierrez-Perez JL, Gili-Miner M. Quality of life in patients with oral and oropharyngeal cancer. Int J Oral Maxillofac Surg. 2009;38:250–5. doi: 10.1016/j.ijom.2008.12.001. [DOI] [PubMed] [Google Scholar]
- 5.Infante-Cossio P, Torres-Carranza E, Cayuela A, Hens-Aumente E, Pastor-Gaitan P, Gutierrez-Perez JL. Impact of treatment on quality of life for oral and oropharyngeal carcinoma. Int J Oral Maxillofac Surg. 2009;38:1052–8. doi: 10.1016/j.ijom.2009.06.008. [DOI] [PubMed] [Google Scholar]
- 6.Pierre CS, Dassonville O, Chamorey E, Poissonnet G, Ettaiche M, Santini J. Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2014;271:801–7. doi: 10.1007/s00405-013-2592-z. [DOI] [PubMed] [Google Scholar]
- 7.Schliephake H, Jamil MU. Prospective evaluation of quality of life after oncologic surgery for oral cancer. Int J Oral Maxillofac Surg. 2002;31:427–33. doi: 10.1054/ijom.2001.0194. [DOI] [PubMed] [Google Scholar]
- 8.Boscolo-Rizzo P, Stellin M, Fuson R, Marchiori C, Gava A, Da Mosto MC. Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: surgery and postoperative radiotherapy versus concurrent chemoradiation. Oral Oncol. 2009;45:953–7. doi: 10.1016/j.oraloncology.2009.06.005. [DOI] [PubMed] [Google Scholar]
- 9.Tucker G, Adams R, Wilson D. New Australian population scoring coefficients for the old version of the SF-36 and SF-12 health status questionnaires. Qual Life Res. 2010;19:1069–76. doi: 10.1007/s11136-010-9658-9. [DOI] [PubMed] [Google Scholar]
- 10.Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83. [PubMed] [Google Scholar]
- 11.Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9. doi: 10.1200/JCO.1993.11.3.570. [DOI] [PubMed] [Google Scholar]
- 12.Borggreven PA, Aaronson NK, Verdonck-de Leeuw IM, Muller MJ, Heiligers ML, Bree R. Quality of life after surgical treatment for oral and oropharyngeal cancer: a prospective longitudinal assessment of patients reconstructed by a microvascular flap. Oral Oncol. 2007;43:1034–42. doi: 10.1016/j.oraloncology.2006.11.017. [DOI] [PubMed] [Google Scholar]
- 13.Klug C, Neuburg J, Glaser C, Schwarz B, Kermer C, Millesi W. Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer. Int J Oral Maxillofac Surg. 2002;31:664–9. doi: 10.1054/ijom.2002.0301. [DOI] [PubMed] [Google Scholar]
- 14.Bozec A, Poissonnet G, Chamorey E, Casanova C, Vallicioni J, Demard F. Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope. 2008;118:874–80. doi: 10.1097/MLG.0b013e3181644abd. [DOI] [PubMed] [Google Scholar]
- 15.Rogers SN, Hannah L, Lowe D, Magennis P. Quality of life 5-10 years after primary surgery for oral and oro-pharyngeal cancer. J Craniomaxillofac Surg. 1999;27:187–91. doi: 10.1016/s1010-5182(99)80049-3. [DOI] [PubMed] [Google Scholar]
- 16.Horney DJ, Smith HE, McGurk M, Weinman J, Herold J, Altman K. Associations between quality of life, coping styles, optimism, and anxiety and depression in pretreatment patients with head and neck cancer. Head Neck. 2011;33:65–71. doi: 10.1002/hed.21407. [DOI] [PubMed] [Google Scholar]
- 17.Bertrand J, Luc B, Philippe M, Philippe P. Anterior mandibular osteotomy for tumor extirpation: a critical evaluation. Head Neck. 2000;22:323–7. doi: 10.1002/1097-0347(200007)22:4<323::aid-hed2>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- 18.Bozec A, Poissonnet G, Chamorey E, Sudaka A, Laout C, Vallicioni J. [Transoral and cervical approach without mandibulotomy for oropharynx cancer with fasciocutaneous radial forearm free flap reconstruction] Ann Otolaryngol Chir Cervicofac. 2009;126:182–9. doi: 10.1016/j.aorl.2009.06.002. [DOI] [PubMed] [Google Scholar]
- 19.Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008;26:3770–6. doi: 10.1200/JCO.2007.14.6647. [DOI] [PubMed] [Google Scholar]
- 20.Ramaekers BL, Joore MA, Grutters JP, van den Ende P, Jong J, Houben R. The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy. Oral Oncol. 2011;47:768–74. doi: 10.1016/j.oraloncology.2011.05.012. [DOI] [PubMed] [Google Scholar]
- 21.Machtay M, Rosenthal DI, Algazy KM, Aviles VM, Chalian AA, Hershock D. Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma. Am J Clin Oncol. 2000;23:509–15. doi: 10.1097/00000421-200010000-00016. [DOI] [PubMed] [Google Scholar]
- 22.Bansal M, Mohanti BK, Shah N, Chaudhry R, Bahadur S, Shukla NK. Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res. 2004;13:481–8. doi: 10.1023/B:QURE.0000018491.80646.bc. [DOI] [PubMed] [Google Scholar]
- 23.Allison PJ, Nicolau B, Edgar L, Archer J, Black M, Hier M. Teaching head and neck cancer patients coping strategies: results of a feasibility study. Oral Oncol. 2004;40:538–44. doi: 10.1016/j.oraloncology.2003.11.008. [DOI] [PubMed] [Google Scholar]
- 24.Hammerlid E, Persson LO, Sullivan M, Westin T. Quality-of-life effects of psychosocial intervention in patients with head and neck cancer. Otolaryngol Head Neck Surg. 1999;120:507–16. doi: 10.1053/hn.1999.v120.a90352. [DOI] [PubMed] [Google Scholar]
- 25.Talmi YP, Horowitz Z, Pfeffer MR, Stolik-Dollberg OC, Shoshani Y, Peleg M. Pain in the neck after neck dissection. Otolaryngol Head Neck Surg. 2000;123:302–6. doi: 10.1067/mhn.2000.104946. [DOI] [PubMed] [Google Scholar]
- 26.Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:401–8. doi: 10.1001/archotol.130.4.401. [DOI] [PubMed] [Google Scholar]
- 27.Pfister DG, Cassileth BR, Deng GE, Yeung KS, Lee JS, Garrity D. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010;28:2565–70. doi: 10.1200/JCO.2009.26.9860. [DOI] [PMC free article] [PubMed] [Google Scholar]